Osteoporosis treatment for high-risk women is cost-effective, with bisphosphonates providing the most benefit at the lowest cost.
Robert Lindsay, MD
Advertisement
Articles by Robert Lindsay, MD
Advertisement
Latest Updated Articles
- Therapies for Treatment of Osteoporosis in US Women: Cost-effectiveness and Budget Impact Considerations
Published: September 15th 2008 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma
2
Guidelines for Bronchiectasis Highlight Multiple Treatment Methods
3
IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?
4
Many US Health Care Workers Face Poverty, Food Insecurity, and Housing Instability
5
